We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$128B
AUM Growth
-$140B
Cap. Flow
-$131B
Cap. Flow %
-102.41%
Top 10 Hldgs %
21.91%
Holding
5,876
New
1,592
Increased
605
Reduced
2,310
Closed
907

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.85B
2
MSFT icon
Microsoft
MSFT
+$1.75B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.22B
4
AMZN icon
Amazon
AMZN
+$1.04B
5
IYR icon
iShares US Real Estate ETF
IYR
+$924M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 14.44%
3 Healthcare 10.25%
4 Consumer Discretionary 9.7%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URGN icon
3876
UroGen Pharma
URGN
$1.86B
$61K ﹤0.01%
6,951
-20,508
-75% -$160K
HMTV
3877
DELISTED
Hemisphere Media Group, Inc.
HMTV
$61K ﹤0.01%
13,333
-16,941
-56% -$102K
CSTE icon
3878
Caesarstone
CSTE
$72.3M
$60K ﹤0.01%
5,805
-23,781
-80% -$282K
CUE icon
3879
Cue Biopharma
CUE
$113M
$60K ﹤0.01%
407
-1,074
-73% -$228K
KSA icon
3880
iShares MSCI Saudi Arabia ETF
KSA
$623M
$60K ﹤0.01%
+1,261
New +$57.3K
MRUS
3881
DELISTED
Merus
MRUS
$60K ﹤0.01%
+2,294
New +$61.5K
SPRY icon
3882
ARS Pharmaceuticals
SPRY
$509M
$60K ﹤0.01%
+17,105
New +$74.5K
SRRK icon
3883
Scholar Rock
SRRK
$5.67B
$60K ﹤0.01%
4,692
-32,342
-87% -$553K
STKS icon
3884
The ONE Group
STKS
$56.2M
$60K ﹤0.01%
5,652
-21,805
-79% -$256K
VSTM icon
3885
Verastem
VSTM
$510M
$60K ﹤0.01%
3,506
-13,930
-80% -$240K
SDC
3886
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$60K ﹤0.01%
+23,127
New +$53.7K
DMTK
3887
DELISTED
DermTech, Inc. Common Stock
DMTK
$59K ﹤0.01%
+4,022
New +$53.8K
RKLY
3888
DELISTED
Rockley Photonics Holdings Limited
RKLY
$59K ﹤0.01%
+14,544
New +$57.8K
ARCO icon
3889
Arcos Dorados Holdings
ARCO
$1.72B
$58K ﹤0.01%
7,194
ARIS
3890
DELISTED
Aris Water Solutions
ARIS
$58K ﹤0.01%
+3,161
New +$45.8K
BWB icon
3891
Bridgewater Bancshares
BWB
$571M
$58K ﹤0.01%
3,420
-22,140
-87% -$386K
FSBC icon
3892
Five Star Bancorp
FSBC
$1.01B
$58K ﹤0.01%
+2,023
New +$61K
IESC icon
3893
IES Holdings
IESC
$14.8B
$58K ﹤0.01%
1,450
-9,061
-86% -$409K
LSPD icon
3894
Lightspeed Commerce
LSPD
$1.31B
$58K ﹤0.01%
+1,873
New +$55.8K
DFTX
3895
Definium Therapeutics
DFTX
$5.78B
$58K ﹤0.01%
+3,485
New +$60.5K
PFIS icon
3896
Peoples Financial Services
PFIS
$704M
$58K ﹤0.01%
1,140
-7,374
-87% -$368K
STRT icon
3897
STRATTEC Security
STRT
$367M
$58K ﹤0.01%
1,531
VCTR icon
3898
Victory Capital Holdings
VCTR
$6.19B
$58K ﹤0.01%
+1,994
New +$65.1K
SEI
3899
Solaris Energy Infrastructure
SEI
$3.15B
$58K ﹤0.01%
5,078
-32,885
-87% -$298K
SHAP.WS
3900
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$58K ﹤0.01%
+285,127
New +$67.6K

Similar funds

Barclays's Q1 2022 Portfolio in Review

As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Barclays opened a new position in Stellantis worth $331M.

  • Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
  • Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
  • Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
  • Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
  • Barclays opened 1,592 new positions and closed 907 in Q1 2022.
  • Barclays's portfolio value fell 52% quarter-over-quarter to $128B.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.